Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

NCT: NCT04192591 · ACTIVE_NOT_RECRUITING

NCT IDNCT04192591

StatusACTIVE_NOT_RECRUITING

Start Date2020-01-30

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2019-12-10

Last updated2026-10-09

Brief Summary

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑